Literature DB >> 8784934

Anti-inflammatory drugs and myorelaxants. Pharmacology and clinical use in musculoskeletal disease.

K B Balano1.   

Abstract

Anti-inflammatory agents and myorelaxants are the cornerstone of pharmacologic management of musculoskeletal disease. Combinations of these drugs are recommended for the treatment of muscle spasm and injury, whereas anti-inflammatory agents alone are used to treat inflammatory pain such as rheumatoid arthritis. Choosing the most effective regimen for patients with pain can be difficult. This article reviews the pharmacology and clinical use of these agents to define how to use these medications better.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8784934     DOI： 10.1016/s0095-4543(05)70280-3

Source DB:  PubMed          Journal:  Prim Care        ISSN： 0095-4543            Impact factor:   2.907


  5 in total

Review 1.  Assessment, Quantification, and Management of Fracture Pain: from Animals to the Clinic.

Authors:  Luke G McVeigh; Anthony J Perugini; Jill C Fehrenbacher; Fletcher A White; Melissa A Kacena
Journal:  Curr Osteoporos Rep       Date:  2020-10       Impact factor: 5.096

2.  Sustained blockade of neurotrophin receptors TrkA, TrkB and TrkC reduces non-malignant skeletal pain but not the maintenance of sensory and sympathetic nerve fibers.

Authors:  Joseph R Ghilardi; Katie T Freeman; Juan M Jimenez-Andrade; William G Mantyh; Aaron P Bloom; Karyn S Bouhana; David Trollinger; James Winkler; Patrice Lee; Steven W Andrews; Michael A Kuskowski; Patrick W Mantyh
Journal:  Bone       Date:  2010-09-18       Impact factor: 4.398

3.  The effect of aging on the density of the sensory nerve fiber innervation of bone and acute skeletal pain.

Authors:  Juan M Jimenez-Andrade; William G Mantyh; Aaron P Bloom; Katie T Freeman; Joseph R Ghilardi; Michael A Kuskowski; Patrick W Mantyh
Journal:  Neurobiol Aging       Date:  2010-10-13       Impact factor: 4.673

Review 4.  New advances in musculoskeletal pain.

Authors:  Susan E Bove; Sarah J L Flatters; Julia J Inglis; Patrick W Mantyh
Journal:  Brain Res Rev       Date:  2008-12-25

5.  Administration of a tropomyosin receptor kinase inhibitor attenuates sarcoma-induced nerve sprouting, neuroma formation and bone cancer pain.

Authors:  Joseph R Ghilardi; Katie T Freeman; Juan M Jimenez-Andrade; William G Mantyh; Aaron P Bloom; Michael A Kuskowski; Patrick W Mantyh
Journal:  Mol Pain       Date:  2010-12-07       Impact factor: 3.395
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.